BiomaLearnFoodsNutrition factsNutrientsGuidesAnswersEvidence

Farro vs quinoa: small lipid drops for quinoa, no human trials for farro

A meta-analysis of 5 randomized trials in 206 adults found quinoa lowered LDL cholesterol by 3.08 mg/dL (95% CI 1.03 to 5.13) and triglycerides by 7.20 mg/dL, from few and small studies. The same analysis reported a 2.8 lb (1.26 kg) drop in body weight, and that result has not held up. A later meta-analysis of 7 trials in 258 adults found no effect on weight (-1.2 lb (95% CI -6.7 to 4.3; metric: -0.54 kg, -3.05 to 1.97)) or BMI against placebo. Both rest on a handful of small trials, so whether quinoa moves weight is still open. For farro there is nothing to report on health. We found no human trial of farro in our sources, and no study comparing the two grains. The two are not interchangeable for people with celiac disease or wheat allergy. Farro is emmer, a wheat, and US and EU allergen rules count it as wheat and as a gluten cereal. On paper they look alike. Per 100 g dry, pearled farro has 12.6 g protein and 7.31 g fiber, and quinoa flour 11.9 g and 6.30 g, from 8 USDA samples each, although that sets a whole grain against a flour.

Every statement here is tied to a source. The badge says what kind of evidence stands behind it: A is a meta-analysis or systematic review, E is the position of an expert body without its own analysis. How we verify →

We have no USDA entry for farro | quinoa itself in this cohort. The evidence below stands on published studies rather than on a composition table, and we would rather say that than show you a number for something else.

How much is actually in it

What a real portion looks like

What your body absorbs

What cooking and storage change

What it does to your health

Safety, limits and interactions

What people believe that the data does not support

Who this works differently for

What is still unknown

The bottom line

Quinoa flour has more fat (6.60 against 3.10 g per 3.5 oz (100 g)) and more iron (4.53 against 3.20 mg), and farro has more zinc (3.97 against 2.77 mg). Iron is the shakiest figure. US quinoa flour samples ranged from 3.55 to 6.6 mg per 3.5 oz (100 g), and the UK table lists raw quinoa grain at 7.8 mg, with grain against flour and different varieties and methods behind the gap. One cup of cooked quinoa weighs 6 oz (170 g) in the US dietary survey. Farro has no survey portion at all, and only 1.07 percent of US adults ate quinoa on a given day in 2013 to 2018. The strongest single trial is in people who already had trouble with blood sugar. In a one-year randomized trial of 207 adults with impaired glucose tolerance, eating quinoa in place of about half their staple food gave better post-meal glucose, lower insulin resistance and fewer cases of diabetes than mixed whole grains or the control diet. The abstract reports P values only, with no sizes, and people with normal glucose were not studied. In 37 healthy overweight men over 4 weeks, bread made with quinoa flour lowered glucose and LDL from baseline, and so did plain wheat bread, with no difference between the two. Laboratory digestion data suggest isolated quinoa starch has a large slowly digested fraction, with no human data behind it. A review of processing says the way quinoa is processed changes its nutrients, without giving any number. The EU refused a claim that quinoa stimulates the hair bulb and helps hair grow, which means the evidence did not meet the bar when assessed. Who should be careful. In 19 adults with treated celiac disease, adding 1.8 oz (50 g) of quinoa a day to a gluten-free diet for 6 weeks was well tolerated and did not make the condition worse, in a study with no control group. That result covers quinoa only and does not carry over to farro. FDA counts every species of the genus Triticum as wheat, a major food allergen, and names emmer among them. EU law lists wheat among the gluten cereals that labels must declare as allergens. In laboratory tests on gut T-cells from celiac children, gluten proteins from most of 9 farro landraces triggered an immune response, 4 strongly and 2 moderately, and 3 barely did. No clinical study has tested farro in people with celiac disease. The nearest is an open study of einkorn, a related ancient wheat. Of 5 celiac patients in remission who finished 60 days of 3.5 oz (100 g) of einkorn biscuits a day, 4 developed severe gut lesions and 3 turned antibody positive. Two others dropped out with returning symptoms. We have no studies on pregnancy or drug interactions for either grain, and none on quinoa allergy.

Each food on its own

Questions answered from the trials

Sources

  1. faqu-daily-r4-01 · food composition dataset
    Farro, pearled, dry, raw | Protein 12.64 G | Fiber 7.31 G (5.68-9.14) | Total lipid 3.103 G | Iron 3.195 MG (2.78-4.21) | Zinc 3.968 MG (2.45-5.0) | samples 8 ; Flour, quinoa | Protein 11.92 G | Fiber 6.295 G (4.35-8.24) | Total lipid 6.601 G | Iron 4.528 MG (3.55-6.6) | Zinc 2.77 MG (2.06-3.25) | Potassium 550.9 MG | samples 8
    USDA FoodData Central, Foundation Foods, release 2026-04-30 (Farro, pearled, dry, raw; Flour, quinoa) · checked 2026-10-02
  2. faqu-daily-r4-02 · food composition dataset
    14-843 Quinoa, raw | Energy 309 kcal | Protein 13.8 g | Fat 5.0 g | Carbohydrate 55.7 g | AOAC fibre 7.0 g | Iron 7.80 mg | Magnesium 210 mg | Zinc 3.3 mg
    CoFID 2021, Public Health England, OGL v3.0, code 14-843 · checked 2026-10-02
  3. faqu-daily-r4-03 · food portion dataset
    56204005 Quinoa, no added fat | 1 cup, cooked 170 g | Quantity not specified 170 g
    USDA FNDDS 2021-2023, food code 56204005 · checked 2026-10-02
  4. faqu-daily-r4-12 · Systematic review
    Digestibility in vitro showed that WSS and QSS presented high SDS fraction, while ASS, MSS, PCSS, and HMT-QSS presented the highest RS content.
    Food Res Int, 2023 · checked 2026-10-02
  5. faqu-daily-r4-11 · Systematic review
    Recent studies have indicated that the diverse utilization and final product quality of this pseudo-grain are closely related to the processing technologies used, which can result in variations in nutritional profiles and health benefits.
    Crit Rev Food Sci Nutr, 2024 · checked 2026-10-02
  6. faqu-daily-r4-04 · Meta-analysis
    The pooled result showed that quinoa seed supplementation significantly lowered the body weight (WMD: -1.26 kg, 95% CI: -2.35, -0.18, p = .02), waist circumference (WC) (WMD: -1.15 cm, 95% CI: -2.08, -0.21, p = .01), fat mass (FM) (WMD: -0.59%, 95% CI: -1.14, -0.03, p = .03), insulin serum level (WMD: -0.86 pmol/L, 95% CI: -13.38, -1.59, p = .01), triglyceride (TG) (WMD: -7.20 mg/dl, 95% CI: -9.52, -4.87, p < .001), total cholesterol (TC) (WMD: -6.86 mg/dl, 95% CI: -10.64, -3.08, p < .001), and low density lipoprotein (LDL) (WMD: -3.08 mg/dl, 95% CI: -5.13, -1.03, p = .003) levels.
    Phytother Res, 2021 · checked 2026-10-02
  7. faqu-daily-r4-06 · Randomized controlled trial
    At the efficacy endpoint, the quinoa group (QG) demonstrated significantly longer time in range (TIR) and normal glucose tolerance (NGT) conversion rate, along with lower rates of 2-hour postprandial glucose (2hPG), fasting insulin (FINS), homeostatic model assessment of insulin resistance (HOMA-IR), 14-day mean blood glucose (14dMBG), and diabetes mellitus development compared to those of the multigrain and control groups (P < 0.05).
    Food Funct, 2025 · checked 2026-10-02
  8. faqu-daily-r4-07 · Randomized crossover trial
    After 4 weeks of intervention, blood glucose and low density lipoprotein (LDL) cholesterol were significantly lower than baseline in both groups but there was no difference between quinoa and control.
    Nutrients, 2018 · checked 2026-10-02
  9. faqu-daily-r4-08 · Cohort study
    Addition of quinoa to the GFD of celiac patients was well tolerated and did not exacerbate the condition.
    Am J Gastroenterol, 2014 · checked 2026-10-02
  10. sf-faqu-hf2-1 · agency guidance
    Wheat is a “major food allergen” under the FD&C Act. For purposes of the definition of a “major food allergen,” the term “wheat” means any species in the genus Triticum. Thus, wheat would include grains such as common wheat (Triticum aestivum L.), durum wheat (Triticum durum Desf.), club wheat (Triticum compactum Host.), spelt (Triticum spelta L.), semolina (Triticum durum Desf.), Einkorn (Triticum monococcum L. subsp. monococcum), emmer (Triticum turgidum L. subsp. dicoccon (Schrank) Thell.), Khorasan (Triticum polonicum L.), and triticale (x Triticosecale ssp. Wittm.).
    US FDA, Questions and Answers Regarding Food Allergens, Including the Food Allergen Labeling Requirements of the FD&C Act (Edition 5), Guidance for Industry, January 2025, section C.9 · checked 2026-10-08
  11. sf-faqu-hf2-2 · regulation
    Cereals containing gluten, namely: wheat (such as spelt and khorasan wheat), rye, barley, oats or their hybridised strains, and products thereof, except:
    Regulation (EU) No 1169/2011 on the provision of food information to consumers, Annex II point 1 (consolidated text 2018-01-01) · checked 2026-10-08
  12. sf-faqu-hf2-3 · laboratory study
    The present study deals with variation in the immune response of mucosal T-cells from celiac children to prolamins extracted from nine landraces of farro wheat (Triticum turgidum ssp. dicoccum) with contrasting storage protein compositions. ... By contrast, landraces Ersa 6, Ersa 8, Leonessa 4 and Leonessa 5 proved to be very active in triggering the immune responses, whereas landraces Filosini and Prometeo exhibited an intermediate behavior.
    Clinical Nutrition, 2009, 28(3):272-277, T-cell response to different cultivars of farro wheat, Triticum turgidum ssp. dicoccum, in celiac disease (Vincentini et al.) · checked 2026-10-08
  13. sf-faqu-hf2-4 · non-randomized clinical trial
    Protocol involved 60-day administration of 100 g/day Tm water biscuits to CD patients in remission on gluten-free diet. ... Eight patients (F/M: 6/2, median age 26) were enrolled. One patient was excluded at T0 because of positive serology, and two patients dropped out because of symptoms recurrence. ... All patients had Marsh II lesion at T0, four had Marsh III and one had recurrence of dermatitis herpetiformis at T60. CD-related antibodies converted from negative to positive at T60 in three patients. ... Our study shows that Tm is toxic for CD patients as judged on histological and serological criteria
    Eur J Nutr, 2015 · checked 2026-10-08
  14. faqu-daily-r4-10 · Regulatory decision
    POL-HC-7865 Quinoa (Chenopodium quinoa) Stimulation of the hair bulb, favouring the growth of the hair Non-authorised
    EU Register on nutrition and health claims, claim POL-HC-7865, snapshot 2026-09-21 · checked 2026-10-02
  15. faqu-daily-r4-09 · Cross-sectional study
    The prevalence of barley, buckwheat and quinoa consumption among US adults were 0.36%, 0.04% and 1.07%, respectively.
    Nutrients, 2025 · checked 2026-10-02
  16. faqu-daily-r4-05 · Meta-analysis
    In comparison between quinoa seed supplementation and placebo, our findings showed that quinoa seed supplementation did not have a significant effect on BMI (MD: -0.25; 95% CI: -0.98, 0.47; I2=0%, P = 0.998) and BW (MD: -0.54; 95% CI: -3.05, 1.97; I2=0%, P = 0.99), when compared with placebo.
    Curr Med Chem, 2024 · checked 2026-10-02

Review. Reviewed on 2026-10-08 for evidence level, dose and population context, and claims a reader could misread. Bioma Learn has no human medical reviewer at this time, and we say so rather than invent one. Methodology. This is information, not medical advice.